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Abstract The aimof the present study was to evaluate exercise limiting factors using cardiopulmonaryexercise test-
ing (CPET) inpatientswith idiopathic pulmonary fibrosis (IPF), and to investigatewhether these parameters are related
to survival after CPET.We evaluated 41patientswith IPF (mean 68.2 years, 27 male) who performed CPET.The exercise
capacityinpatientswith IPF was limitedmore strongly bygas exchange and/or ventilatory impairments, comparedwith
cardiac impairment.Using univariate analysis, the severity of exercise-induced hypoxemia (EIH) evaluated by DPaO2/
D _VO2 (PaO2-slope), oxygen uptake at maximum exercise, oxygen pulse at maximum exercise, ventilatory equivalent
for carbon dioxide at maximum exercise and age were significantly related to the survival rate. Interestingly, the PaO2-
slopewasmostclosely correlatedwith the survival rate usingmultiple analysiswith a stepwise evaluation.Nevertheless,
PaO2 atrest and atmaximumexercisewerenotfactorsinfluencing survival.Inpatientswith IPF,CPET can simultaneously
evaluatethe abilityof boththe cardiovascular andrespiratory systems, and shouldbe available sothatparameters canbe
derivedtomakethenecessaryprognosticestimations, withthemostusefulparameterbeing the degree of EIHasrepre-
sented by the PaO2-slope.r2002 Elsevier Science Ltd.Allrights reserved.
doi:10.1053/rmed.2002.1469, available online athttp://www.sciencedirect.com
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Idiopathic pulmonary ¢brosis (IPF) is a chronic progres-
sive disorder of unknown origin, and the mean survival
times of patients are reported to range from 3 to 6 years
(1).
Among various physiological and morphological fea-
tures of patients with IPF, exercise-induced hypoxemia
(EIH) has been reported to considerably correlate with
the grade of histopathological damage of the biopsy spe-
cimens (2), and to functionally limit exercise perfor-
mance (3, 4).However, EIH has not yet been established
as a prognostic factor.
Recently, patients with various kinds of lung diseases,
including IPF, have undergone lung transplantation (5^7).
It is suggested, however, that evaluation of cardiopul-
monary impairments, which determine the prognosis of
IPF patients and individualizedrespiratory care appropri-
ate to thepathophysiologyof eachpatient, are necessary
to increase the opportunities for available treatmentsReceived18 December 2001, accepted in revised form 29 August 2002
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prognosis. In the present study, we investigatedwhether
parameters in cardiopulmonary exercise testing (CPET)
were related to the prognosis of patients with IPF.
MATERIALSANDMETHODS
Patients
Forty-one patients (mean 68.2 years, 27 males) with IPF
in Toneyama National Hospital between January, 1993
and August,1999 were included in the present study. All
patients had coughs and dyspnea on e¡ort. Diagnosis of
IPF was according to clinical criteria (8). Patients with
connective tissue diseases, sarcoidosis, bronchiolitis ob-
literans with organizing pneumonia, eosinophilic pneu-
monia, hypersensitivity pneumonitis, primary cardiac
diseases, anemia, peripheral vascular diseases, cancer,
and/or anydisorders of thepleura or chestwall, including
respiratory muscle weakness, were excluded from the
study. Furthermore, patients were excluded if they
underwent corticosteroid or immunosuppressive treat-
ment before entry into the study, or died from a cause
other than respiratory failure during the follow-up.
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tained from all patients before clinical examination.
Study design
At the diagnosis of IPF,PFT (with anAutospirometer Sys-
tem 9, Minato Medical Science; Osaka, Japan) was per-
formed within 2 weeks prior to CPET.CPET (9^11) was
performed on a treadmill (Aeromill 2000, Nihon Koden;
Tokyo, Japan) with continuous monitoring of a 12-lead
electrocardiogramandbloodpressure (Fig.1).Theproce-
dures for CPETwere as follows.While breathing with a
mask, thepatients exercised on a treadmillwithprogres-
sive increments in 3min stages according to the She⁄eld
protocol and amodi¢ed She⁄eldprotocol (Fig.1) (9).We
selected the increment size after considering the inten-
sity of the patient’ s daily activity and parameters of pul-
monary function. Progressive incremental exercise
testing was performeduntil the subjects revealed symp-
toms or signs indicating the exercise should stop (i.e.
breathlessness, ST segment depression greater than
2mm, or a short run of premature ventricular contrac-
tions on ECG).Exercise and gas exchangemeasurements
were collectedcontinuouslyusing a Respiromonitor RM-
200 (Minato Medical Science; Osaka, Japan). Arterial
blood samples were drawn through an indwelling radial
artery cannula under local anesthesia.Using a blood gas
analyzer (288 Blood Gas System,Ciba Corning; MA), ar-
terial blood gases were measured before exercise withFIG. 1. Protocol for the treadmill exercise test.ECG=electrocard
arterial-line.Expiredgas analysis; fordetails see text.the patient sitting, and during the last 15 s of each exer-
cise stage. Simultaneously, blood samples were assayed
to clarify the lactate (Lt) level in the plasma. After CPET,
a follow-up was performed on all patients (mean, 2.7
years; 7.2 months to 9.0 years). If our medical records
were incomplete, wemade adequate inquiries to the lo-
cal physician.
Parameters
As parameters for PFT, the forced expiratory volume in
1s (FEV1.0), forced vital capacity (FVC), vital capacity
(VC), total lung capacity (TLC), and carbon monoxide
di¡using capacity (DLCO) weremeasured.The values for
VC and DLCO were based on those of Baldwin et al. (12)
and Burrows et al. (13), respectively. As parameters for
CPET, arterial oxygen pressure (PaO2), arterial carbon
dioxide pressure (PaCO2), heart rate (HR), respiratory
frequency (f ), tidal volume (VT), minute ventilation ( _VE),
oxygen uptake ( _VO2), ventilatory equivalent for oxygen
( _VE / _VO2) and carbon dioxide ( _VE / _VCO2), oxygen pulse
( _VO2/HR), and alveolar^arterial oxygen pressure di¡er-
ence (AaDO2) were measured during exercise, and
DPaO2/D _VO2 (PaO2-slope ) was calculated. As an index
of EIH severity, we used the PaO2-slope. PaO2 was
plotted against _VO2 from rest to the maximum stage
achieved (14).
The predicted peak _VO2 was calculated using the for-
mula of Wasserman et al. (10).The peak _VE at maximumiogram;BP=blood pressure; ABG=arterial blood gases; A-line=-
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used as a measure of breathing reserve, using the indir-
ect MVV (10) calculated by FEV1.0 40. Using linear re-
gression, a slope (PaO2-slope) was obtained for each
subject. As indices of cardiac function, we used the HR
increase (DHR/D _VO2), _VO2/HR and heart rate reserve
(HRR) (10). The following equation can be used to esti-
mate HRR.
HRR (%) can be estimated by (1-observed maximum
HR/predictedmaximumHR) 100.
Radiography
Standard posteroanterior chest radiographs, the con-
ventional and high-resolution computed tomography
scanswere assessed independentlyby three experienced
readers. Agreement of all three readers was required to
con¢rm the chest radiographic diagnosis. Diagnosis was
undertaken by examining for the presence and distribu-
tion of intralobular reticular areas of opacity, honey-
combing, areas of ground-glass attenuation,
consolidation, and nodules (8, 15, 16). Patients were ex-
cluded from the study if all three readers did not agree
on their diagnosis of IPF according to their HRCT ¢nd-
ings.
Statistical analysis
We employed several statistical methods to evaluate
prognostic factors for IPF in terms of survival rate (Stat-
View 4.5; Abacus Concepts; Berkeley, CA). The values
are shown asmean7 SD or percentages of the total va-
lues.First, univariate analysiswas carriedoutusingCox’s
proportional hazardsmodel (17). All variables suggested
by the univariate analysis or those judged to be clinically
appropriate were entered into multiple analysis using
stepwise evaluation (see Results). The relationship be-
tween the PaO2-slope (dependent variable) and other
cardiopulmonary parameters (independent variables)
was analysed using linear regression with the stepwise
technique. The survival times were calculated using the
Kaplan^Meier method (18), and statistical signi¢cance
was determinedwith the log rank test. Patients were di-
vided into two groups according to themean level of the
PaO2-slope. Parameters collected during exercise for
the two groups were compared using the Mann^Whit-
ney test.
RESULTS
Clinical characteristics
Table 1 summarizes patient clinical characteristics. No
patient stopped the exercise test due only to leg fatigue.
Exercise performance in all patients was moderately orseverely reduced (mean oxygen uptake at maximum
exercise; 16.075.1ml/kg/min).
Relationship between exercise capacity and
cardiopulmonary parameters
An analysis of the relationship between exercise capacity
and the cardiopulmonary parameters is shown inTable 2
and Fig. 2.The percentage of predicted peak oxygen up-
take signi¢cantly correlatedwith the circulatory, ventila-
tory, andgas exchangeparameters on statistical analysis.
However,HRR showeda negative correlation to exercise
performance; the smaller the HR atmaximum exercise,
the lower the exercise capacity.Themost signi¢cant cor-
relation was found between the ventilatory equivalent
for carbondioxide andexerciseperformance.These ¢nd-
ings suggest that patients with IPF actually demon-
strated signi¢cant exercise limitations in both
ventilatory andgas exchange (including PaO2-slope)with
cardiovascular disorders ( _VO2/HR atmaximumexercise)
during the exercise test.
Prognostic factors
Twenty-three (56%) patients enrolled in the studydiedof
respiratory failure during the follow-up period.The cor-
relation between the ¢ndings of the exercise test and
survival time (median survival, 2.9 years) after CPETwas
analysed statistically. Using univariate analysis, ¢ve fac-
tors ( _VO2 at maximum exercise, _VO2/HR at maximum
exercise, PaO2-slope, _VE / _VCO2 at maximum exercise,
and age) were signi¢cantly associated with the survival
time, as indicated inTable 3. In stepwise multiple regres-
sion analysis, only two factors, the PaO2-slope and age,
provided independent prognostic information. Of all
parameters, the PaO2-slopewasmost closely correlated
with the survival time.When patients were divided into
two groups, steep (r60mmHg/l/min, n=18) andgentle
(460 mmHg/l/min, n=23), according to themean level
of the PaO2-slope, survival time after CPETwas signi¢-
cantly shorter in the steep group (median survival, 1.6
years) than in the gentle group (median survival, 4.5
years) (Fig. 3).The cause of deathwas respiratory failure
in all patients.
The number of patients who had been prescribed
long-term oxygen therapy (LTOT) after examination
was17 of18 (94%) in the steep group, and 22 of 23 (96%)
in the gentle group (data not shown). The mean age, at
CPET, of patients who died during the follow-up period
was not signi¢cantly di¡erent between the two groups
(steep group, 70.777.5 years; gentle group, 68.4 7 4.9
years; data not shown).No di¡erential e¡ectof LTOTbe-
tween the two groups for survival time was clear, be-
cause the number of cases with LTOT did not
TABLE 1. Characteristics of all patients (n=41)
Mean7 S.D. or No.(%)
Age (years) 68.277.0
Gender: male/female 27/14
Smoking: never/ former/current (%) 39.0/36.6/24.4
Chest-X-ray Category:1/2/3/4 (No.) 10/14/13/4
Pulmonary functiontest: FEV1.0 (l) 1.770.5
FEV1.0/FVC (%) 87.379.3
VC (l) 2.170.7
VC (% predicted) 69.0718.5
DLCO (% predicted) 44.1714.9
Exercise test:
_VO2, atmax. ex. (ml/min/kg) 16.075.1
Circulatoryparameters:
HR, atmax. ex. (beats/min)
131.9721.0
Lt, atmax. ex. (mg/dl) 29.9718.1
HHR (%) 12.9713.7
Gas exchange parameters: PaO2, at rest (mmHg) 83.5712.9
PaO2, atmax. ex. (mmHg) 52.9711.5
_VE/ _VCO2 , atmax. ex. 52.0712.5
Ventilatoryparameters: _VE, atmax. ex. (l/min) 43.6714.5
VT, atmax. ex. (l) 1.170.4
_VE, atmax. ex./MVV (%) 79.5724.7
Values aremean7 SD or No. (percentage).Chest X-raycategory:
category1=smallrounded opacities, absentor less profuse than in category 2.
category 2=smallrounded opacities de¢nitelypresent but fewinnumber.
category 3=numerous smallrounded opacities, the normallungmarkings are usually still visible.
category 4=verynumerous smallrounded opacities, the normallungmarkings are partlyor totallyobscured.
FEV1.0: forced expiratory volume in1s;FVC: forcedvital capacity;VC: vital capacity;
DLCO: carbonmonoxide di¡using capacity;HR: heart rate;Lt: lactate;HHR:Heart rate reserve;
_VO2: oxygen uptake; PaO2: arterial oxygen pressure; _VE: minute ventilation; _VCO2: carbon dioxide output; _VE/ _VCO2: venti-
latoryequivalent for CO2;VT: tidalvolume;MVV: maximumvoluntary ventilation; max. ex.: maximumexercise.
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been prescribed LTOT in their clinical course.
Adetailedassessmentofthe steep groupand
the gentle group
Tables 4 and 5 provide a detailed assessment of both
groups. In the steep group, decreased VC and DLCO and
severe radiographical lesions were found more
frequently. Also, values of f and ( _VE at rest were signi¢-
cantly higher compared with those in the gentle group,
because the ventilatory equivalents ( _VE/ _VO2 and _VE /
_VCO2) at rest were signi¢cantly poorer in the steep
group.During exercise the ventilatory equivalents in the
steep group were also signi¢cantly poorer than those in
the gentle group. At maximum exercise, oxygen uptake
in the steep group was signi¢cantly smaller than that in
thegentle group.Theplasma lactate titer andHR atmax-
imum exercise were signi¢cantly lower in the steep
group, accompanied by smaller peak oxygen uptake lim-
ited by ventilatory and gas exchange disorders.This wasbecauseHRR in the steep group (17.7713.5%) was signi¢-
cantly larger than that in the gentle group (9.0713.0%).
Additionally, the HR increase (steep group, 8.475.9
beats/100ml; gentle group, 7.473.3 beats/100 ml;
data not shown) did not signi¢cantly di¡er between the
two groups. These ¢ndings suggest that the ventilatory
and gas exchange factors were more signi¢cantly
impaired in the steep group compared with the gentle
group.
The following equation between the PaO2-slope and
parameters of the pulmonary function test at rest was
derived using a stepwise technique:
PaO2-slope (mmHg/l/min)=43.70.8 PaO2(mmHg)
+7.0DLCO(ml/min/mmHg), r2=0.50, po0.001. The
PaO2-slope could not be accurately predicted by para-
meters at rest.
DISCUSSION
In the present study, we assessed the limiting factors
of exercise capacity, and retrospectively found that
TABLE 2. Correlation betweenthe percentage of predictedpeakoxygenuptake and cardiopulmonaryparameters
r pvalue
Circulatoryparameters
HR, atmax. ex. (beats/min) 0.633 o0.0001
HRR (%) 0.622 o0.0001
Lt. atmax. ex. (mg/dl) 0.594 o0.0001
_VO2/HR, atmax. ex. (ml/beats) 0.554 0.0002
Gas exchange parameters
DLCO (ml/min/mmHg) 0.579 0.0010
PaO2-slope (mmHg/l/min) 0.464 0.0022
PaO2, at rest (mmHg) 0.399 0.0098
AaDO2, at rest (mmHg) 0.465 0.0022
_VE/ _VO2, atmax. ex. 0.554 0.0002
_VE/ _VO2, at rest 0.532 0.0003
_VE/ _VCO2, atmax. ex. 0.696 o0.0001
Ventilatiotryparameters
TLC (% predicted) 0.609 0.0006
VC (% predicted) 0.335 0.0399
_VE, atmax. ex. (l/min) 0.425 0.0056
For abbreviation de¢nitions, seeTables1. _VO2/HR: oxygenpulse;PaO2-slope: DPaO2/D _VO2; AaDO2: alveolar-arterial oxy-
gen pressure di¡erence; _VE/ _VO2: ventilatory equivalent for O2; _VE/ _VCO2: ventilatory equivalent for CO2;TLC: total lung
capacity.
FIG. 2. Relationship of _VE/ _VCO2 atmaximum exercise (A),HR atmaximum exercise (B), and PaO2-slope (C) to the percentage of
predictedpeakoxygenuptake.
486 RESPIRATORYMEDICINEcardiopulmonary exercise parameters could predict the
prognosis of respiratory failure in patients with IPF.
Exercise capacity and impairments
Exercise capacity in patients with IPF was shown to be
mainly limited by gas exchange and ventilatory impair-ments. Previous studies have shown that in patientswith
IPF, EIH is an important limiting factor for exercise per-
formance and also that peak oxygen uptake, maximal
workload, peak minute ventilation, and exercise dura-
tion are increased by augmenting the concentration of
inspired oxygen during incremental exercise (3,10). We
suggest that arterial hypoxemia, rather than ventilatory
impairment, predominantly limits incremental exercise.
TABLE 3. Factors fromclinical ¢ndings on survival
Univariate analysis Multiple regression analysis
Hazardratio 95% CI pvalue Hazard
ratio
95% CI pvalue
Circulatoryparameters
HR, atmax. ex. (beats/min) 0.981 0.963 ^ 1.000 0.056
Heart rate reserve (HRR) (%) 1.020 0.989 ^ 1.051 0.206
Oxygenpulse ( _VO2/HR), atmax. ex. (ml/beats) 0.690 0.512 ^ 0.929 0.014
_VO2, atmax. ex. (ml/min/kg) 0.997 0.995 ^ 0.999 0.012
Lt, atmax. ex. (mg/dl) 0.976 0.944 ^ 1.008 0.141
Gas exchange parameters
DLCO (% predicted) 1.009 0.974 ^ 1.045 0.622
PaO2-slope (per10%) (mmHg/l/min) 0.677 0.514 ^ 0.893 0.006 0.841 0.731 ^ 0.967 0.015
PaO2 atmax. ex. (mmHg) 0.975 0.936 ^ 1.016 0.230
Ventilatoryequivalent for O2, ( _VE/ _VO2), atmax. ex. 1.018 0.989 ^ 1.047 0.230
Ventilatoryequivalent for CO2, ( _VE/ _VCO2), atmax. ex. 1.036 1.006 ^ 1.067 0.020
Ventilatoryparameters
VC (% predicted) 0.977 0.951 ^ 1.003 0.079
TLC (% predicted) 0.996 0.966 ^ 1.028 0.817
FEV1.0/FVC (per10%) (%) 1.088 0.646 ^ 1.832 0.752
_VE, at rest, (l/min) 1.101 0.998 ^ 1.214 0.054
Breathingreserve, ( _VE/MVV), atmax. ex. (%) 0.990 0.974 ^ 1.007 0.264
Others
Age (years) 1.099 1.019 ^ 1.184 0.014 1.096 1.012 ^ 1.187 0.025
Gendermale/female 0.607 0.519 ^ 3.075 0.607
Smoker/non-smoker 0.979 0.415 ^ 2.314 0.962
For abbreviation de¢nitions, seeTables1and 2.CI: con¢dence interval.
FIG. 3. Survival curves according to the level of the PaO2-
slope. CPET=cardiopulmonary exercise testing. Solid line=-
PaO2-sloper60mmHg/l/min (n=18); dashed line=PaO2-slo-
pe460mmHg/l/min (n=23); po0.005, bylog-rank test.
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tion perfusion ( _VA/ _Q) mismatching and shunts did not in-
crease from resting, while the percentage of AaDO2 due
to O2 di¡usion-limitation increased to 40% from about
20% at rest, using a multiple inert gas technique. In the
present study, mean AaDO2 also increased from about20 to 45mmHg during exercise. Recently, experimental
studies showed thatDLCO and the degree of disturbance
in gas exchange in patientswith IPFweremutually corre-
lated with the severity of the histopathological distur-
bance (2,20).
We found that ventilatory impairment was consistent
with a limiting factor for exercise because the ventilation
/MVVratio (79.57 24.7%) was high, and the respiratory
rate was strikingly elevated at maximum exercise (rapid
shallow type breathing).Therefore, we conclude that the
increase in ventilatory equivalents for oxygen and carbon
dioxide is caused by gas exchange and ventilatory ab-
normalities, and also that oxygenation factors, rather
than circulatory factors, are primarily responsible for ex-
ercise limitation, based on our observations that exercise
was stoppeddue to EIH level and/or ventilatorydisorders
before the cardiovascular systemwasmaximally stressed.
Survival and impairments
In the present study, the survival period of patients
whose exerciseperformancewasmoderatelyor severely
limitedwas poor with a median survival of 2.9 years.We
found that the PaO2-slope, theventilatory equivalent for
carbon dioxide, oxygen pulse and oxygenuptake atmax-
imum exercise, as well as age, were useful as prognostic
TABLE 4. Comparison ofthe steep andgentle groups
PaO2-slope (mmHg/L/min)
r60 (n=18) 460 (n=23) pvalue
Age (years) 70.276.4 66.777.2 N.S.
Gendermale/female 11/7 16/7 N.S.
Smoking: never/former/current (%) 44/38/18 35/39/26 N.S.
Treatment (after examination): corticosteroids or pulse therapy (No.) 1/18 2/23 N.S.
Chest X-ray, pattern:1/2/3/4 (No.) 2/5/9/2 8/9/4/2 po 0.05
LDH (IU/l) 420.0772.7 432.8781.7 N.S.
Duration fromonsetto examination (months) 32.8729.6 25.6732.9 N.S.
Pulmonary functiontest
VC (l) 1.970.6 2.370.7 po 0.05
VC (% predicted) 61.2717.1 75.2717.6 po 0.05
TLC (l) 3.071.0 3.771.0 N.S.
FEV1.0 (l) 1.570.6 1.870.5 N.S.
FEV1.0/FVC (%) 87.977.3 86.9710.8 N.S.
DLCO (ml/min/mmHg) 5.771.9 7.772.9 po 0.05
DLCO (% predicted) 39.5713.2 48.4715.4 N.S.
For abbreviation de¢nitions, seeTables1and 2.LDH:Lactate dehydrogenase;Values aremean7 SD.N.S.: not signi¢cant.
TABLE 5. Comparison of cardiopulmonaryresponses to the exercise testofthe steep andgentle groups
Exercise test Atrest
PaO2-slope (mmHg/l/min)
pvalue Atmax. ex
PaO2-slope (mmHg/l/min)
pvalue
r60 (n=18) 460 (n=23) r60 (n=18) 460 (n=23)
Circulatoryparameters
HR (beats/min) 91.2717.9 87.5717.9 N.S. 123.0718.9 139.3720.2 po 0.05
_VO2/HR (ml/beat) 3.270.9 3.170.5 N.S. 5.671.3 7.571.7 po 0.01
_VO2 (ml/min/kg) 5.571.4 4.771.2 N.S. 13.272.9 18.275.5 po 0.01
Lt (mg/dl) 10.073.5 8.774.0 N.S. 22.079.3 36.1720.9 po 0.01
HHR (%) 17.7713.5 9.0713.5 po 0.05
Gas exchange parameters
PaO2 (mmHg) 83.3714.6 83.7711.7 N.S. 49.979.3 55.2712.7 N.S.
AaDO2 (mmHg) 21.6713.9 19.4711.5 N.S. 49.7714.1 44.8712.3 N.S.
_VE/ _VO2 61.779.4 53.0710.6 po 0.01 57.0711.2 46.8711.1 po 0.05
_VE/ _VCO2 61.779.4 53.0710.6 po 0.01 58.3712.9 47.079.9 po 0.01
Ventilatoryparameters
f (breath/min) 31.8711.3 23.475.6 po 0.05 46.1716.6 41.078.3 N.S.
PaCO2 (mmHg) 36.574.8 37.574.3 N.S. 40.478.0 39.975.1 N.S.
VT (l) 0.670.2 0.670.1 N.S. 0.970.3 1.270.4 N.S.
_VE (l/min) 17.174.3 13.673.4 po 0.05 38.5710.2 47.6716.3 N.S.
_VE atmax. ex./MVV (%) 81.7727.0 77.8723.2 N.S.
For abbreviation de¢nitions, seeTables1^3.Values aremean7 SD; f: respiratory frequency;PaCO2: arterial carbon dioxide
pressure.
488 RESPIRATORYMEDICINEpredictors of survival.With respect to the dependency
of PaO2 on age (21), we carried out an analysis to investi-
gatewhether the PaO2-slopewas dependent on age, but
no correlation between the PaO2-slope and agewas de-
tected. Furthermore, the mean age of patients was not
signi¢cantly di¡erent between the steep and gentle
groups. In addition, the PaO2-slope was a more signi¢-
cant predictive parameter for the survival rate than agein our multivariate models. These ¢ndings suggest that
among the above ¢ve parameters, the degree of the
PaO2-slope is the most useful factor for survival, inde-
pendent of age.The present ¢ndings suggested that the
degree of the Pao2-slopemost accurately represents the
reserve of the cardiopulmonary system.
Several studieshave reportedclinical andphysiological
factors in relation to the prognosis of IPF patients (1, 22,
IMPAIRMENTSANDPROGNOSTICFACTORS INIPF 48923). Erbes noted that diminished survival was associated
with a lowerTLC alone or in combinationwith a reduced
VC and age, but not with parameters of gas exchange at
rest and PaO2 during bicycle exercise in IPF patients;
however, the PaO2-slope was not calculated (1). In the
present study, parameters of gas exchange, excluding
the PaO2-slope, were also not useful predictors of survi-
val.
The cardiovascular responses for the increase of
oxygen uptake were also similar between the two
groups. However, ventilation was more severely
impaired in the steep group, because of the unusually
large ventilatory requirement (shown by ventilatory
equivalent for oxygen) in patients with severe EIH and
reduced ventilatory capacity. The PaO2-slope and the
ventilatory equivalent for carbon dioxide can be im-
provedbyrespiratoryrehabilitation (e.g. the suppression
of rapid breathing, the increase in tidal volume and the
inhalation of oxygen) during exercise. If these para-
meters are improved, the survival of IPF patients may
also be improved.
We found a signi¢cant linear correlation (r=0.584) be-
tween the PaO2-slope and DLCO at rest. The present
evaluation of the PaO2-slope using a stepwise technique
for parameters of the pulmonary function test at rest
revealed that the r2 value was only 0.5. Therefore, the
PaO2-slope could explain only 50% using the parameters
of the pulmonary function test at rest. These ¢ndings
show that abnormalities of the pulmonary function test
identi¢ed at rest cannot accurately predict the magni-
tude of the Pao2-slope.CPET is useful to evaluate cardio-
pulmonary disorders (e.g. ventilatory limiting, gas-
exchange limiting, and cardiovascular limiting) and the
prognostic predictors of IPF patients.
In addition to the clinical factorsmentioned above, the
histologic ¢ndings were also regarded as a most impor-
tant prognostic predictor for patients with IPF (23).
However, in the present study, not all patients could
undergo open lung biopsy, so histologic ¢ndings in terms
of a prognostic factor could not be studied. Neverthe-
less, we included patients in the present study who met
the clinical criteria of IPF as describedpreviously (8). As a
result, the survival (median survival, 2.9 years) in the
present study was similar to that (median survival, 2.8
years) of patients with usual interstitial pneumonia
reported previously (23).
In summary, the ¢ndings of the present study
suggest that the degree of EIH can be used to predict
survival after CPET in patients with IPF, and that CPET
should be made available to make prognostic estima-
tions, giving unique information about ventilatory, gas-
exchange, and cardiovascular disorders.With the devel-
opment of available treatments for IPF, it is important to
now assess how to evaluate and care for patients with
IPF, taking into account the degree of EIH in their every-
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